IL25 and cancer: Here, we found that sustained innate IL-25 and ILC2 signals helped to maintain a cancer-permissive microenvironment in intestinal polyps and colorectal adenocarcinoma, by preventing anti-tumoral T cell and IFNγ-mediated immunity.